Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

680 Articles

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 6, 2018 at 8:55 AM EST

20 More Biopharma Catalysts Coming in 2018

Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves…

Jon C. Ogg | Jan 5, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

The top analyst upgrades, downgrades and other research calls from Friday include Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 24, 2017 at 12:25 PM EDT

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

Jon C. Ogg | Oct 18, 2017 at 2:10 PM EDT

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 10, 2017 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Alphabet, Check Point Software, Chesapeake Energy, Chevron, Intel,…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

1 … 24 25 26 27 28 … 46

Eli Lilly : LLY

All Eli Lilly Articles

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Back Way Off Major Pharma

Short Sellers Hike Bets in Major Pharma

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

QDTE’s Yield Keeps Shrinking as Volatility Slides Below 15

Stocks Are Finally Pulling Back and These Buffer ETFs Still Promise 100 Percent Downside Protection

Worked 10 Years? Your Spouse Who Never Paid a Dime Into Medicare Gets Part A Free at 65 on Your Record

Worked 10 Years? Your Spouse Who Never Paid a Dime Into Medicare Gets Part A Free at 65 on Your Record

He Maintained a Neighborhood Bike Station for Free Rides. Social Security Could Count Them as Pay.

QDTE’s Yield Keeps Shrinking as Volatility Slides Below 15

Stocks Are Finally Pulling Back and These Buffer ETFs Still Promise 100 Percent Downside Protection

Eli Lilly : LLY

All Eli Lilly Articles

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Back Way Off Major Pharma

Short Sellers Hike Bets in Major Pharma

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

QDTE’s Yield Keeps Shrinking as Volatility Slides Below 15

Stocks Are Finally Pulling Back and These Buffer ETFs Still Promise 100 Percent Downside Protection

Worked 10 Years? Your Spouse Who Never Paid a Dime Into Medicare Gets Part A Free at 65 on Your Record

Featured Reads

Worked 10 Years? Your Spouse Who Never Paid a Dime Into Medicare Gets Part A Free at 65 on Your Record

He Maintained a Neighborhood Bike Station for Free Rides. Social Security Could Count Them as Pay.